NIKKEI 225
25,984.51 -587.36 (-2.21%) HANG SENG
17,499.30 -361.01 (-2.02%) CRUDE OIL
77.48 -1.02 (-1.30%) GOLD FUTURES
1,632.00 -4.20 (-0.26%) DOW
29,134.99 -125.82 (-0.43%) BTC-GBP
17,563.49 -1,395.38 (-7.36%)
Moderna, Inc. (MRNA)
After hours:
| Previous close | 119.69 |
| Open | 120.58 |
| Bid | 122.30 x 1000 |
| Ask | 122.47 x 1100 |
| Day's range | 120.25 - 125.16 |
| 52-week range | 115.61 - 397.98 |
| Volume | |
| Avg. volume | 4,864,022 |
| Market cap | 49.558B |
| Beta (5Y monthly) | 1.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.96 |
| Earnings date | 02 Nov 2022 - 07 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 220.67 |
- Motley Fool
Why Moderna Stock Crushed the Market Today
The coronavirus pandemic might, just might, be easing, but top COVID-19 vaccine maker Moderna (NASDAQ: MRNA) was ascendant on Tuesday. Shortly before market close on Monday, the Food and Drug Administration (FDA) announced it had authorized a set of Moderna's latest Spikevax COVID booster vaccine for use. Strictly speaking, that company isn't covered under Moderna's emergency use authorization (EUA) for the booster.
- Yahoo Finance Video
The new minimum corporate tax will hit these companies the hardest, according to expert
University of North Carolina Kenan-Flagler Business School Associate Professor Jeffrey Hoopes joins Yahoo Finance Live to explain why the new 15% minimum corporate tax rate would hit companies like Amazon and Berkshire Hathaway the hardest.
- Motley Fool
Down 85%, Is There Any Hope for This Struggling Vaccine Stock?
In the early days of the pandemic, if there was one coronavirus vaccine stock investors were betting on, it was Novavax (NASDAQ: NVAX). The biotech stock soared more than 2,700% in 2020 as it developed its vaccine candidate. In the same timeframe, Pfizer shares hardly budged.
